Food allergens of plant origin - the relationship between
allergenic potential and biological activity

PROTALL participants

The following individuals and organisations from 13 countries contributed to the PROTALL project during its lifetime:

Austria
Belgium
Denmark
Finland
France
Greece
Ireland
Israel
Italy
Netherlands
Spain
Sweden
UK
Location of Protall Partners

   

Austria

Flag

  • Dr Karin Hoffmann-Sommergruber
  • Dr Heimo Breiteneder
  • Professor Dietrich Kraft
  • Dr Christoff Ebner
  • Professor Otto Scheiner

Divisions of Immunopathology, Applied Experimental Pathology and General and Experimental Pathology, University of Vienna.(WGs1 and 3)

Three working groups will be involved, Biotechnology and Biochemical Diagnostics (headed by Dr Breiteneder), Allergy Research (headed by Dr. Ebner) and Molecular Immunopathology (headed by Dr. Valenta). The research of these groups is focussed on the production of recombinant tree pollen and food allergens, their immunological and molecular characterisation, together with investigating the functional aspects of plant allergens. Research is also focussed on clinically observed allergic cross-reactions to pollen and food allergens, together with animal models for Type I allergic reactions.

  • Dr Peter Remler

Department of Food Chemistry, Graz University of Technology. (WG2)

The research team has an interest in allergic reactions to food proteins, and the effects of processing on allergenic activity. Contributions will involve investigating the effects of hydrolysis of purified allergens supplied by other partners, on cytokine secretion of human cell lines obtained from cord blood. There is also an interest in using immunological methods for following changes in allergens after processing and their detection on foods. Expertise in the assembly of databanks will also be brought to the project as members of the team have been involved in establishing one covering the availability of foods free from allergens or intolerant substances (eFID-databank).

TOP

Belgium

Flag

  • Dr Lien-Ahh Tran
  • Dr James Astwood

International Life Sciences Institute (ILSI) European Branch, Allergy Task Force, Brussels. (WGs2 and 3)

International Life Sciences Institute (ILSI) as a nonprofit worldwide foundation established in 1978 to advance the understanding of scientific issues relating to nutrition, food safety, toxicology, risk assessment and the environment. It is affiliated to the World Health Organisation as a non-governmental organisation and has specialised consultative status with the Food and Agriculture Organisation of the United Nations.

ILSI Europe was created to focus on the specific needs defined by the Institute's European partners. Its main goals are to:

  • foster scientific advances by promoting collaboration among scientific experts in industry, academia, and national and international regulatory bodies

  • provide coherent scientific answers to issues of common concern for the well-being of the general public

  • support an active publication programme for the dissemination of scientific information to the broadest possible audience including the scientific community, international organisations and regulatory agencies

James Astwood from Monsanto is contributing directly to the Protall workprogramme. This is being done through sharing information between the Allergy Task Force and the Protall consortium. The ILSI Task force also form an important link for dissemination of information to the European food industry.

TOP

Denmark

Flag

  • Dr Charlotte Madsen

Institute of Food Safety and Toxicology, Danish Food and Veterinary Administration, Soeborg. (WG1)

IFT will contribute to the project in a number of ways. An oral infant rat model for assessing sensitisation to allergens in the young is being developed. This will be used to study sensitisation to allergens supplied by other partners. The rats' response will be determined using, for example, serum IgE and IgG levels, together with histopathological examination of intestine and related lymphoid tissue. Finally IFT will contribute to the discussion on important allergenic foods that might be included in a database. IFT is already involved in the EU network on natural toxicants, NETTOX, which does not include information on allergens at present.

TOP

Finland

Flag

  • Dr Erika Isolauri

Nutrition and Allergy related to Mucosal Immunology (NAMI) Group, Department of Paediatrics, Turku University. (WG1)

The NAMI group will contribute to the project by evaluating the immunological activity of purified allergenic proteins, supplied by other partners, using children with documented food allergies. The effects of the plant food proteins on gut mucosal barrier function will also be assessed, together with an immunological evaluation of the gut humoral response together with cytokine generation, both in vivo and in vitro.

TOP

France

Flag

  • Dr Marie-Francoise Gautier

INRA Unitede Biochemie et Biologie Moleculaire des Cereales, Montpellier. (WG3)

For many years the UBBMC has been studying the genes encoding low molecular weight cysteine-rich proteins from wheat. Certain of these, the CM proteins, have been found to be involved in determining the surface state of cooked pasta. Furthermore the lipid-transfer proteins (LTPs) and puroindolines have a high affinity for lipid and are thought to play a role in determining bread-making quality. In addition to their relevance in determining the technological properties of food, the LTPs and puroindolines have anti-fungal activities, whilst the CM proteins are a -amylase inhibitors. It is a long term goal to manipulate these proteins in order to improve the technological properties of wheats by genetic engineering to modify their properties and/or by genetic transformation. The contribution to the project will be to produce purified wheat cysteine-rich proteins for assessment of their allergenic potential and to produce modified (by site directed mutagenesis) or hybrid proteins, in order to identify sequences important for allergenicity. Transgenic plants superexpressing cysteine-rich proteins will also be analysed when available.

  • Dr Didier Marion

INRA Laboratoire de Biochemie et Technologie des Proteines, Nantes. (WG2)

LBTP is composed of different units among including one involved in the purification of proteins at laboratory and pilot scale (S.BEROT, J.P.COMPOINT), immunochemistry (T.GABORIT), biochemistry and biophysics (D.MARION, J.PDOULIEZ, G.COMPOINT). In this concerted action we will perform large scale purification of some plant lipid binding proteins including puroindolines, lipid transfer proteins and thionins for exchange with other partners. We will also use various monoclonal and polyclonal antibody preparations to these proteins to probe them during food processing. We will also investigate their lipid binding properties as necessary, as well as providing other partners with different lipoprotein complexes.

  • Dr Xavier Morge

SPI-BIO, Paris. (WG2)

The company has great experience in the exploitation of molecular methods (both genetic and immunological) and providing them in a suitable format for use by researchers. Thus using purified proteins, and possible antibody preparations available from other partners, assays maybe developed for determining the presence of allergens in foods, or for monitoring the alterations in allergen structure resulting from processes, such as cooking. In certain instances antibody preparations maybe developed to purified allergens to facilitate assay development. The assays would also be applicable to clinical studies for monitoring the uptake of dietary allergens into the circulation.

  • Dr Jean-Michel Wal

Laboratoire d'Immuno-Allergie Alimentaire, Laboratoire Associe INRA-CEA, Paris. (WG1)

Development of methods for the evaluation of allergic hazards due to food or technology additives and natural or processed food proteins also constitutes an important element of the research projects on toxicological aspects of food safety at INRA. The team has been much involved in the study of protein technology and digestion of food proteins for many years. Techniques for controlled and modeled hydrolysis, artificial digestion, preparation and identification of pure peptides form part of the Institute's expertise. The team also has a great deal of experience in mapping the allergenic epitopes of food allergens. This expertise will be brought to bear using the purified protein allergens supplied by other partners.

TOP

Greece

Flag

  • Dr Photini Papageorgiou

Allergy Unit, P & A Kyriakou Chideren's Hospital, University of Athens. (WG1)

The Allergy Unit is a paediatric allergy referral centre which sees in excess of 60000 patients a year. This will ensure that sufficient patients with food allergy can be identified to undertake the work proposed. The Immunology Laboratory is part of the University Research Laboratory and is equipped to support the in vitro part of the study which will be to investigate T-cell mediated immune responses. The tasks will be incorporated in the current research programme dealing with the immune response to food allergens, in an effort to advance and develop reliable diagnostic procedures in food allergy.

TOP

Ireland

Flag

 

  • Dr Bruce Mitchell

Blackrock Clinic, Blackrock, Co. Dublin, Ireland

TOP

Israel

Flag

  • Dr Shahal Abbo

Faculty of Agriculture and Environmental Quality Services, The Hebrew University of Jerusalem, Rehovot. (WG3)

The teams interests are focussed around the genetic basis of yield physiology in grain legume crops such as chickpea. Attempts are being made to combine day-length insensitivity with high biomass production. Such a combination will allow the productivity of crops to be increased in arid zones without the need for supplementary irrigation. Another research objective is to understand the genetic basis of nutritional characters (eg. calcium or carotenoid contents) and their relationship with yield parameters and fungal resistance. This expertise will bring the aspects of crop physiology and genotype x environment interactions to bear on the allergenicity of proteins which may be important in conferring fungal resistance to plants.

  • Dr Ram Reifen

The Institue of Biochemsitry, Nutrition and Food Science, The Hebrew University of Jerusalem, Rehovot. (WG1)

The clinical practice of the team leader at the hospital is primarily concerned with treating patients with gastrointestinal and nutritional problems among which food allergy is a major component. Patients are also treated who have inflammatory bowel disease and other gastrointestinal abnormalities associated with digestion, absorption and allergic reactions to foods. The contribution to the project would centre around these patients and investigating their reactivity (humoral responses) in vitro using allergens supplied by other partners. A human nutrition unit for obtaining blood and tissue samples is available at the two participating medical centres. Reactivity to allergens will be determined using a range of biochemical methods.

  • Dr Shmuel Yannai

Technicon, Haifa. (WG2)

The interests of the research team are focussed around the effects of processing and food component interactions on the ability of food allergens to stimulate the immune system. Plant foods will be subjected to various different types of treatment, including heat, homogenisation (shear), acid and alkali. Complexes of allergens with lipid, carbohydrate, as well as protein-protein aggregates which may have formed through cross-linking or as a consequence of protein unfolding during processing, will be isolated. The allergenic potential of these samples will be determined by using animal models following IgG and IgE levels, histological analysis of the intestinal mucosa and related lymph nodes, together with alterations in mast call protease II.

TOP

Italy

Flag

  • Professor Vincenzo Buoncore

Diprtimento di Agrobiologia e Agrochimica, Universita della Tuscia, Viterbo. (WG3)

The group is actively involved in the isolation and characterisation of proteins and genes related to pathogenesis, also known as PR proteins. These have been isolated from wheat and include the group 4 (wheatwins) and group 6 (WTI, a trypsin inhibitor) which are strong inhibitors of phytopathogenic fungi. A number of allergens from birch and other tree pollens are homologous to PR proteins. As PR proteins are target transgenes and subjects for mutagenesis to create forms with enhanced activity, their potential allergenicity is an issue of importance. Class 4 and 6 PR proteins will therefore be isolated for use by other partners in assessing their allergenicity. The primary structure of the proteins will be determined and compared with known allergens. PR proteins of other classes with potential allergenic features will be identified.

  • Professor Elide Pastorello

Regional Reference Centre for Allergic Disease, Osperdale Maggiore di Milano. (WG1)

The research of the team is focussed on the so called ‘oral allergy syndrome' (OAS). which is generally observed in response to fruits and vegetables. Such reactions are also commonly associated with sensitisation to pollens, particularly from mugwort and birch. Research is underway to identify and characterise new food allergens from vegetables using sera from patients with OAS for fruits or vegetables. Especial attention will be paid to patients with allergy to tomato as the allergens in this fruit have yet to be identified. This work will also make use of relevant proteins available from other partners.

TOP

Netherlands

Flag

  • Dr Robert Brummer

Department of Gastroenterology, University Hospital, Maastricht. (WG1)

The research team has a great interest in the role of food allergy in the appearance of abdominal complaints, especially in conjunction with functional abdominal complaints or chronic inflammatory bowel disease. Because of the drawbacks of IgE RAST testing in adults with food allergy, a project has started in which colonic intramucosal allergen injection is evaluated. Furthermore, the department has broad scientific experience in the determination of small bowel permeability. A novel method to determine colonic permeability will be evaluated soon. The department will contribute to the project by contributing to a serum and mucosal specimen bank from patients with known (multiple) food allergies. This will be used to evaluate plant allergens from other partners in clinical studies ( possibly by intramucosal injection) or in vitro using cell lines to determine cell permeability. The department may contribute to in vitro and in vivo studies to elaborate whether a change in small bowel/colonic permeability has a predictive value for, or may serve as a sensitive parameter of the process of sensitisation to a food allergen.

  • Dr Hubert Noteborn

RIKILT-DLO, Wageningen. (WG1)

RIKILT-DLO has a high level of expertise in the area of food safety evaluation of foods, including novel foods, including those originating from GMOs. Contributions will therefore focus around these areas, using existing testing methods to assess the allergenic potential of purified proteins from other partners in the project.

  • Frans van Dam

Stichting Consument en Biotechnologie, Den Haag. (WG2)

The Consumer and Biotechnology foundation has many years experience in consumer related issues regarding genetically modified foods. One of the main items has been the safety of genetically modified foods for human consumption, including the issue of food allergy in relation to genetic engineering. It is also of interest to the organisation to translate new scientific knowledge into regulation aimed at consumer protection and consumer information. The contribution to the project will mainly focus on the consumers interest in scientific research and dissemination of the results of the project to an audience of consumer organisations and their members.

  • Dr Harry Wichers

Agrotechnological Research Instutue (ATO-DLO), Wageningen. (WG2)

As a consequence of better preservation of sensory and health-related quality attributes of food products, there is a general tendency to apply less stringent processing techniques in the manufacture of foods. Such milder processing methods will, however, also affect the allergenic properties of food products. The feasibility of a combined biochemical and physical approach to processing can be evaluated by characterising the effects of protease treatment and mild physical processing on the structure of epitopes in proteinaceous food allergens. Once such epitopes have been identified proteases of suitable specificity will be selected to irreversibly modify the epitope structure. The effects of a limited number of physical treatments, such as time-temperature combinations, on epitope structure will also be assessed. Epitope integrity will be assessed by following the interaction between modified epitopes and suitable antibody preparations using immunochemical assays.

TOP

Spain

Flag

  • Professor Manuel Rico

Instituto de Estructura de la Materia, CSIC, Madrid. (WG3)

The main objective of the research undertaken by the group is to understand protein folding and stability. Such studies require a sound background in methods of structure determination. The group has contributed some original methodology in that area and the laboratory is a national facility for protein structure determination by NMR, determining structures of proteins supplied by research groups all over Spain. Some of the recently assigned structures have been for plant proteins, one of them, napinIb being a 2S albumin seed protein, which is highly homologous to the major allergen of mustard, sinIa. This expertise will be brought to bear on the relevant tasks of the project, especially the identification of common structures of allergens, and the application of that knowledge to the prediction of allergenic determinants in novel proteins.

  • Professor Rosalia Rodriguez
  • Dr Rafael Monsalve

Departmento de Biochimiqua y Biologia Moleculair, Universidad Complutense, Madrid. (WG3)

The research of the team is focussed on the detection, isolation and analysis of allergens from different plant sources, including mustard seeds and olive tree pollen. More recently recombinant allergens have been produced to study the cross-reactivity of allergens from different plants. The team will contribute purified natural and recombinant allergens, together with chimeric proteins for use in the structural, immunological and biological analysis of allergens. These preparations will also be available for clinical studies and the analysis of the cross-reactive nature of many plant allergens. The thermal and proteolytic stability of allergens, their detection on seeds, fruits and vegetables will also be covered.

  • Dr Gabriel Salcedo
  • Dr Maria Rosa Sanchez-Monge

Department de Biotechnologia Unidad de Bioquimica, Universidad Politecnica Madrid. (WG3)

Purified wheat, barley and rye allergens associated with baker's asthma will be analysed with respect to the biochemical properties of the allergens, and clinical data relating to their allergenic properties. This will include a family of a -amylase inhibitors, of which there are around 15 members, and an endosperm specific peroxidase. The role of complex asparagine-linked glycans play in conferring the allergenic properties of certain plant proteins, especially in relation to heat-stable epitopes, will be investigated. In addition putative ‘panallergens' implicated in the ‘latex-fruit' syndrome will be characterised at a biochemical level. The biological activity of the isolated proteins, both in vivo and in vitro will be assayed.

TOP

Sweden

Flag

  • Dr Vaidrius Navikas
  • Gran Akesson

SIK, Lund. (WG2)

SIK has an ongoing research programme into the effects of process induced changes in protein structure on immunological molecular recognition events. This covers unfolding and exposure of hydrophobic domains. There is also an interest in applying immunological methods to monitoring structural changes in allergens during food processing, with particular emphasis on the detection of allergens in food. Thus contributions to the project will focus on characterising alterations to food allergens during processing and interactions with food components, using biochemical and immunological methods.

  • Dr Lars Yman

Pharmacia and Upjohn Diagnostics, Uppsala. (WG1)

Pharmacia & Upjohn Diagnostics has been involved in research, development, and marketing of immunoassay systems for the measurement of allergen specific IgE antibodies. The current allergen research programme includes immunochemical characterisation of allergen sources, allergen molecular biology, studies on pure allergenic proteins produced by recombinant techniques, together with clinical studies on the properties and performance of allergens and allergen reagents.

TOP

United Kingdom

Flag

  • Dr Richard Weightman

DuPont Cereals Innovation Centre, Cambridge. (WG2)

DuPont Cereals Innovation Centre is a biotechnology company involved in the production of food, medical and industrial products. Among the activities which are undertaken at the research centre is the development of new functional protein products. It is of interest to investigate the allergenicity of these protein products and to understand how processing effects allergenicity. Protein samples from different plant sources, produced by different processes, can be supplied to other partners for evaluation.

  • Rene Crevel
  • Dr Paul Davis

Unilever Research, Sharnbrook. (WGs1 and 2)

The SEAC Toxicology laboratory has extensive expertise in using in vitro and in vivo toxicological studies, including those for assessing the allergenicity of substances. In addition to having projects involved in validating procedures for determining the immunotoxic potential of substances, studies have also been undertaken to investigate the effects of high fat diets on the immune response. The methodology in place for these projects will be used to assess the allergenic potential of protein preparations supplied by other partners in the project.

  • Dr Keith Atherton

Zeneca-Central Toxicology Laboratory, Macclesfield, Cheshire. (WG3)

  • Dr Clare Mills
  • Dr Annette Fillery-Travis

Institute of Food Research, Norwich. (WG2)

The expertise of the team is focussed on investigating the role of lipids and proteins at interfaces found extensively in food systems, such as foams and emulsions. Thus the surface active properties of proteins provided by other partners, and their interactions with lipids will be determined using a range of interfacial methods. This research interest has also been used to investigate the effect of surface active components (such as bile salts) and dietary lipids on the bioavailability of vitamin A from carrots. Model systems that mimic the pH and composition of the gut have been developed and these will be used to ascertain the effect of lipids and bile components on the uptake of allergens by the gut.

  • Professor Peter Shewry
  • Dr Arthur Tatham

Long Ashton Research Station, Bristol. (WG3)

The research team has extensive experience in the purification and characterisation of plant proteins. The contribution to the project will be based on this expertise. Thus in relation to sub-task 1.2 information will be supplied on allergens from wheat and related cereal grains, the 2S albumins of dicotyledonous seeds, including walnut, Brazil nut, castor bean, cottonseed, oriental mustard and yellow mustard, together with the storage globulins of soyabean and peanut. With respect to task 2 work will focus on the 2S albumins, using structural prediction, modelling and biophysical (spectroscopic) studies to compare their structures and stabilities. Non-allergenic 2S albumins, notably from sunflower, will be used in addition to the previously characterised allergens listed under sub-task 1.2. On the basis of data from these tasks the utilisation of allergens and related proteins (e.g. non-allergenic methionine-rich 2S albumins) in transgenic plants.

With regards supply of proteins (sub-task 4.1) proteins prepared will include prolamins (from wheat), 2S albumins (from sunflowers and other species, depending on the availability of samples from other participants) and lipid binding proteins (PLTPs) from sunflower. The conformation of related allergenic and non-allergenic proteins prepared under sub-task 4.1 will be compared using spectroscopic methods.

  • Professor John Warner
  • Kate Grimshaw

Department of Child Health, University of Southampton. (WG1)

The research group has extensive expertise in the area of allergy, and has ongoing research projects to investigate the role certain allergens play in the development of severe allergic reactions to certain foods such as peanuts. Clinical cases of peanut allergy have been enrolled in studies and a clinical suite for investigations involving patients is available. These resources, together with laboratories for in vitro tests involving cell culture and purification and characterisation of proteins, will be used to assess the allergenic potential of proteins supplied by other partners in the project.

  • Mr David Reading

Anaphylaxis Campaign, PO Box 149, Fleet, Hampshire GU13 9XU

The Anaphylaxis Campaign is a registered charity which spreads awareness and educates the public about life-threatening food allergies. It produces a wide range of information sheets and videos, primarily targeted at patients but also at the food industry, health professionals, educational establishments, Government agencies and other bodies. There is also a strong campaigning role, particularly in the field of food labelling. The Campaign is guided by some of the leading allergy experts in the UK, including Prof John Warner. With 6,000 members by the summer of 2000, the Campaign feels it has a wealth of experiences from which to draw, and is in a good position to represent the patient's interest.

  • Dr Bryan Hanley

  • Dr Heather Hird

Central Science Laboratory, York

TOP

 

NAVIGATION:

Funded through the EU FAIR Programme

home | about food allergy | PROTALL database | links | newsletters | project summary | contact us